Adiponectin, Leptin, and Resistin in Asthma: Basic Mechanisms through Population Studies

Area of Science:

• Immunology
• Endocrinology
• Respiratory Medicine

Background:

• Adipokines are signaling molecules from adipose tissue with diverse roles.
• Leptin and adiponectin are key adipokines with opposing effects on inflammation.
• Adipokines may influence the development and exacerbation of asthma.

Purpose of the Study:

• To review mechanistic, population-based, and clinical data on adipokines in asthma.
• To explore the specific roles of adiponectin and leptin in asthma pathogenesis.
• To assess the potential for adipokine modulation in asthma prevention and treatment.

Main Methods:

• Review of mechanistic studies in animal models.
• Analysis of population-based epidemiological studies.
• Examination of clinical data from human subjects.

Main Results:

• Adiponectin administration reduced allergic airway inflammation and hyperresponsiveness in mice.
• Low serum adiponectin correlates with increased asthma risk in women and girls.
• Higher leptin levels are linked to increased asthma prevalence and severity, especially in females.

Conclusions:

• Adiponectin appears to have a protective role in asthma, while leptin may exacerbate it.
• Evidence suggests a significant link between adipokine profiles and asthma outcomes.
• The therapeutic potential of targeting adipokines for asthma management requires further investigation.